Constipation in pediatric cystic fibrosis patients: an underestimated medical condition

H P J van der Doef1, F T M Kokke, F J A Beek

  • 1Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA, Utrecht, The Netherlands. H.P.J.vanderdoef@umcutrecht.nl <H.P.J.vanderdoef@umcutrecht.nl>

Insights

Constipation affects nearly half of pediatric Cystic Fibrosis (CF) patients, linked to poor fat absorption and meconium ileus. Abdominal X-rays offer limited value for routine CF care.

Area of Science:

  • Gastroenterology
  • Pediatrics
  • Pulmonology

Background:

  • Constipation is a common complication in Cystic Fibrosis (CF).
  • Understanding its prevalence, risk factors, and diagnostic tools is crucial for patient management.
  • Abdominal radiography is often used, but its diagnostic utility requires evaluation.

Purpose of the Study:

  • To determine the prevalence and risk factors of constipation in pediatric CF patients.
  • To assess the effectiveness of abdominal radiography in diagnosing constipation in CF.
  • To identify key factors associated with constipation in this population.

Main Methods:

  • A cohort of 214 pediatric CF patients was studied.
  • Abdominal radiographs from 106 CF patients were assessed using Barr and Leech scores by multiple observers.
  • Statistical analysis identified independent risk factors for constipation.

Main Results:

  • Constipation prevalence was 47% in the studied CF cohort.
  • Low total fat absorption and a history of meconium ileus were significant independent risk factors.
  • Inter- and intraobserver variability for radiography scoring was poor to moderate, indicating limited reliability.

Conclusions:

  • Constipation is a significant issue in Cystic Fibrosis, strongly associated with impaired fat absorption and meconium ileus.
  • Abdominal radiography demonstrates limited value for the routine follow-up of CF patients regarding constipation.
  • Further research into optimal constipation management strategies in CF is warranted.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...